THIRD AMENDED AND RESTATED SECURITY AGREEMENTSecurity Agreement • August 29th, 2012 • Protalex Inc • Services-commercial physical & biological research • New York
Contract Type FiledAugust 29th, 2012 Company Industry JurisdictionTHIS THIRD AMENDED AND RESTATED SECURITY AGREEMENT (this “Agreement”), dated as of June 5, 2012, is made by and among Protalex, Inc. a Delaware corporation, (the “Grantor”), and Niobe Ventures, LLC (the “Secured Party”) and amends and restates in its entirety the Second Amended and Restated Security Agreement dated as of February 11, 2012 by and between Grantor and Secured Party.
PROTALEX, INC. Form of Stock Option Agreement (this “Agreement”)Stock Option Agreement • August 29th, 2012 • Protalex Inc • Services-commercial physical & biological research
Contract Type FiledAugust 29th, 2012 Company IndustryProtalex, Inc., a Delaware corporation (the “Company”), hereby grants to John E. Doherty (the “Optionee”), a stock option to purchase a total of 200,000 shares of the Company's Common Stock, par value $.00001 per share (the “Common Stock”), at a price of $1.01 per share (the “Exercise Price”).
PROTALEX, INC. Form of Stock Option Agreement (this “Agreement”)Stock Option Agreement • August 29th, 2012 • Protalex Inc • Services-commercial physical & biological research
Contract Type FiledAugust 29th, 2012 Company IndustryProtalex, Inc., a Delaware corporation (the “Company”), hereby grants to Kirk M. Warshaw (the “Optionee”), a stock option to purchase a total of 250,000 shares of the Company's Common Stock, par value $.00001 per share (the “Common Stock”), at a the price of $1.01 per share (the “Exercise Price”).